Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Triple-blind Treatment

Effect of Peripheral Magnetic Stimulation in Patients With Chronic Lower Back Pain

Low Back Pain

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Oswestry Disability Index (ODI) — 15.1; 15.0; 13.7; 4.6 Scores on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
rPMS Intervention (Device); rPMS Controle (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Inês Gomes
Primary completion
Nov 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Oswestry Disability Index (ODI)
15.1; 15.0; 13.7; 4.6
SECONDARY
Pain Intensity at Rest (VAS)
3.2; 3.4; 2.9; 2.0
SECONDARY
Pain Intensity During Activity (VAS)
5.3; 5.4; 4.7; 2.8
SECONDARY
Pressure Pain Threshold Right Lumbar Region
5600; 5700; 6100; 7500
SECONDARY
Pressure Pain Threshold Left Lumbar Region
5300; 5400; 5900; 7300
SECONDARY
Lumbar Mobility (Schober Test)
15.1; 15.0; 15.7; 16.5
SECONDARY
Oswestry Disability Category
1.4; 1.3; 1.2; 0.5
SECONDARY
Physical Activity Level (IPAQ)
0.5; 0.6; 0.5; 0.6

Summary

The aim of this study is to analyze the effect of Repeated Peripheral Magnetic Stimulation (rPMS) in patients with chronic low back pain. This is a controlled, randomized, multicenter clinical trial (Brazil x Portugal). The sample will consist of individuals with chronic low back pain with a score between 40 and 80 on the Oswestry scale, who will be randomly divided into 2 groups: control (CG) and intervention (IG). The instruments used for evaluation will be: visual analog pain scale (VAS), brief pain inventory (BPI), McGill questionnaire, Roland Morris scale and WHOQOL-BREF. Both groups will use the EMP device, with 10 sessions over a period of 2 weeks, in the IG applied in the flat tangential orientation lasting 20 minutes and an intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest with a minimum intensity of 20% up to the maximum intensity to induce sufficient contraction of the paraspinal muscle and in the CG in transverse orientation with the stimulus intensity level set at 5% of the maximum output of the stimulator to minimize stimulation, both in the most painful lumbar region. The Wilcoxon test will be applied. Then, the Mann-Whitney test will be applied, adopting a significance level of 5%. It is expected that this research will contribute to more accurate protocols and evaluation methods for the EMP intervention, which generates responses in pain relief and non-surgical treatment.

Eligibility Criteria

Inclusion Criteria

Individuals with complaints of low back pain for more than three months

Non-practitioners of sports activities

Absence of significant spinal pathologies, such as previous history of myelopathies, surgeries, instabilities, or deformities (bone fractures)

Normal neurological examination for radiculopathies (patellar and Achilles tendon reflexes, voluntary motor function, and sensitivity test)

Exclusion Criteria

Presence of trauma or systemic dysfunction

Use of other alternative treatments

Refusal to be randomized

Protrusion or prolapse of one or more intervertebral discs with neurological symptoms

Previous spinal surgery

Infectious spondylopathy

Low back pain secondary to inflammation, tumor, or autoimmune disease

Congenital spinal deformities

Compression fracture caused by osteoporosis, spondylolysis, or spondylolisthesis

Use of prosthesis

History of seizures or epilepsy

Implanted or non-removable intracranial metal or devices

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07243548). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search